Q3 2024 Holdings
Filed 2024-11-14 | 84 holdings | $423.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $39.7M | 401,505 | 9.4% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $27.9M | 13,680,554 | 6.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $23.5M | 517,994 | 5.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.0M | 398,100 | 5.0% |
| Merus N V | COM | N5749R100 | $20.6M | 412,573 | 4.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $18.0M | 641,673 | 4.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $14.9M | 471,410 | 3.5% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $14.9M | 102,500 | 3.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $13.4M | 89,572 | 3.2% |
| Axogen Inc(AXGN) | COM | 05463X106 | $13.1M | 935,894 | 3.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.3M | 121,763 | 2.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.8M | 273,739 | 2.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $10.5M | 750,363 | 2.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.1M | 526,702 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $9.4M | 187,130 | 2.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $8.7M | 204,208 | 2.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.4M | 723,678 | 2.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.0M | 69,615 | 1.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.0M | 408,368 | 1.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.0M | 125,616 | 1.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $6.1M | 227,906 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.8M | 458,915 | 1.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.1M | 667,000 | 1.2% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.7M | $4,000,000 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.4M | 65,552 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.3M | 73,754 | 1.0% |
| Alector Inc(ALEC) | COM | 014442107 | $4.3M | 912,928 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.9M | 256,717 | 0.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.7M | 130,175 | 0.9% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.7M | 15,900 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.4M | 120,700 | 0.8% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.2M | 494,274 | 0.8% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.1M | 230,322 | 0.7% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $3.0M | 630,029 | 0.7% |
| Acelyrin Inc | COM | 00445A100 | $3.0M | 602,894 | 0.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $2.9M | 1,050,118 | 0.7% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.9M | 589,561 | 0.7% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.9M | 1,704,232 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.8M | 254,165 | 0.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.8M | 122,200 | 0.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.5M | 207,427 | 0.6% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $2.3M | 251,346 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $2.3M | 250,583 | 0.5% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.2M | 1,222,358 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $2.2M | 148,294 | 0.5% |
| Inogen Inc(INGN) | COM | 45780L104 | $2.0M | 208,790 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.9M | 120,351 | 0.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.8M | 146,500 | 0.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.8M | 486,667 | 0.4% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.7M | 145,000 | 0.4% |